Frequency-doubled Nd: YAG laser versus argon-green laser photocoagulation in proliferative diabetic retinopathy: A preliminary report

R. Brancato, F. Bandello, G. Trabucchi, R. Lattanzio

Research output: Contribution to journalArticle

Abstract

Twenty eyes of 16 diabetic patients affected by proliferative diabetic retinopathy were randomly treated with frequency-doubled Nd:YAG (532 nm) and argon-green (514 nm) lasers. Each of the two groups consisted of ten eyes. The mean follow-up period was 5.80 months (SD=1.36) in the first group and 5.70 months (SD=1.77) in the second group. Evolution of visual acuity and regression of new vessels were similar in the two treatment groups. The authors discuss the clinical results in the light of the histological data present in the literature and of data they have obtained in one human eye. On the basis of their preliminary results, the authors underline the practical advantages of the employment of the frequency-doubled Nd:YAG laser in clinical practice.

Original languageEnglish
Pages (from-to)97-102
Number of pages6
JournalLasers and Light in Ophthalmology
Volume4
Issue number2
Publication statusPublished - 1991

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Frequency-doubled Nd: YAG laser versus argon-green laser photocoagulation in proliferative diabetic retinopathy: A preliminary report'. Together they form a unique fingerprint.

  • Cite this